Skip to main content
SpringerLink
Log in

ESMO Virtual World Congress on Gastrointestinal Cancer 2021

MSI-H/dMMR-CRC: Langzeitdaten bestätigen Immuntherapie

  • Onkologie aktuell
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. POMME-med GmbH, Von-Erckert-Str. 48, 81827, München, Deutschland

    Petra Ortner

Authors
  1. Petra Ortner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ortner, P. MSI-H/dMMR-CRC: Langzeitdaten bestätigen Immuntherapie. InFo Hämatol Onkol 24, 55–57 (2021). https://doi.org/10.1007/s15004-021-8794-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-021-8794-4

Search

Navigation